Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE1345.7525.95 (+1.97 %)
PREV CLOSE () 1319.80
OPEN PRICE () 1323.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4352
TODAY'S LOW / HIGH ()1299.30 1350.00
52 WK LOW / HIGH ()1075 2249.65
NSE1346.8024.1 (+1.82 %)
PREV CLOSE() 1322.70
OPEN PRICE () 1332.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1346.80 (110)
VOLUME 218471
TODAY'S LOW / HIGH() 1299.70 1350.00
52 WK LOW / HIGH ()1057 2248
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007

Management Info :

Arun Kumar - Chairman Neeraj Sharma - Managing Director

Registered Office :

Address : Unit No. 902, Cyber One,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone : 022 2789 2924

Email : cs@stelis.com

Website : www.stelis.com

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
12Feb OneSource Specialty Pharma informs abo
Pursuant to Regulation 30 read with read with Para A of Part A of Schedu..
11Feb OneSource Specialty Pharma informs ab
OneSource Specialty Pharma has informed that it enclosed Press Release i..
11Feb OneSource Specialty Pharma secures SFD
OneSource Specialty Pharma has received Saudi Food and Drug Authority (S..
11Feb OneSource Specialty Pharma moves up on
Onesource Specialty Pharma is currently trading at Rs. 1196.75, up by 3...
03Feb Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed that it enclosed disclosure unde..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit-621.85193.1
Gross Profit -621.85 -214.55
Operating Profit 174.563869.57
Net Sales 2902.212995.89
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26495.15 (0.61%)
M.Cap ( in Cr)
56300.34
Kwality Pharma (BSE)
 1555.85 (6.24%)
M.Cap ( in Cr)
1614.38
Bharat Parenterals (BSE)
 1142.50 (3.67%)
M.Cap ( in Cr)
787.41
Sai Life Sciences (BSE)
 998.10 (3.52%)
M.Cap ( in Cr)
21136.58
Mercury Laboratories (BSE)
 829.00 (2.59%)
M.Cap ( in Cr)
99.48
Shareholding Pattern
NON-INSTITUTION 32.15%
PROMOTERS 29.93%
MUTUAL FUNDS/UTI 9.02%
FI/BANKS/INSURANCE 2.53%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81287.19-961.42 (-1.17%)
NIFTY25178.65-317.90 (-1.25%)
Dow Jones 49499.2017.05 (0.03%)
Nasdaq 22878.38-273.70 (-1.18%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI